BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32366449)

  • 1. Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
    Sim J; Wi YC; Park HY; Park SY; Yoon YE; Bang S; Kim Y; Jang K; Paik SS; Shin SJ
    Anticancer Res; 2020 May; 40(5):2961-2967. PubMed ID: 32366449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.
    Sim J; Kim Y; Kim H; Bang S; Jee S; Park S; Shin SJ; Jang K
    In Vivo; 2020; 34(1):125-132. PubMed ID: 31882471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma.
    Jee S; Kim H; Bang S; Kim Y; Park HY; Paik SS; Sim J; Jang K
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.
    Zhao T; Ding X; Chang B; Zhou X; Wang A
    BMC Cancer; 2015 Mar; 15():203. PubMed ID: 25885343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low MTUS1 Protein Expression Is Associated with Poor Survival in Patients with Colorectal Adenocarcinoma.
    Park H; Jee S; Son H; Cha H; Bang S; Ahn BK; Myung J; Paik S; Kim H
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
    Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
    Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma.
    Ding X; Zhang N; Cai Y; Li S; Zheng C; Jin Y; Yu T; Wang A; Zhou X
    Mol Oncol; 2012 Feb; 6(1):73-80. PubMed ID: 22153618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma.
    Kobayashi G; Sentani K; Babasaki T; Sekino Y; Shigematsu Y; Hayashi T; Oue N; Teishima J; Matsubara A; Sasaki N; Yasui W
    Cancer Sci; 2020 Mar; 111(3):1020-1027. PubMed ID: 31912588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
    White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
    Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability.
    Lv Q; Dong F; Zhou Y; Cai Z; Wang G
    Cell Death Dis; 2020 Dec; 11(12):1056. PubMed ID: 33311452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.